Q1 2024 · 13F-HR
Bruce & Co., Inc.holdings as filed
Filed 2024-05-13 · accession 0001104659-24-060446
$301.5M
Reported value
39
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 023586506 | UHAL/B | Uhaul B | $32.9M | 10.9% | 493,350 | Common | SOLE |
| 589331107 | — | Merck | $29.1M | 9.66% | 220,700 | Common | SOLE |
| 00287Y109 | ABBV | Abbvie | $25.1M | 8.34% | 138,000 | Common | SOLE |
| 020002101 | ALL | Allstate | $22.0M | 7.30% | 127,200 | Common | SOLE |
| 26441C204 | DUK | Duke Energy | $19.7M | 6.54% | 203,890 | Common | SOLE |
| 125896100 | CMS | CMS Energy | $19.1M | 6.32% | 316,000 | Common | SOLE |
| 302571104 | — | Nextera Energy | $18.8M | 6.22% | 293,600 | Common | SOLE |
| 002824100 | ABT | Abbott | $17.0M | 5.65% | 150,000 | Common | SOLE |
| 00206R102 | T | AT & T | $16.9M | 5.61% | 961,000 | Common | SOLE |
| 45774W108 | IIIN | Insteel | $13.1M | 4.35% | 343,423 | Common | SOLE |
| 98389B100 | XEL | XEL Energy | $10.4M | 3.44% | 193,000 | Common | SOLE |
| 717081103 | PFE | Pfizer | $7.5M | 2.47% | 268,500 | Common | SOLE |
| 05379B107 | AVA | Avista | $7.1M | 2.34% | 201,500 | Common | SOLE |
| 237266101 | DAR | Darling Ingredients | $7.0M | 2.31% | 150,000 | Common | SOLE |
| 91911K102 | — | Bausch Health | $6.8M | 2.27% | 644,000 | Common | SOLE |
| 037833100 | AAPL | Apple | $6.0M | 2.00% | 35,100 | Common | SOLE |
| H11356104 | BG | Bunge | $5.1M | 1.70% | 50,000 | Common | SOLE |
| 023586100 | UHAL | Uhaul | $4.8M | 1.59% | 70,805 | Common | SOLE |
| 268311107 | EDAP | EDAP | $4.1M | 1.35% | 553,652 | Common | SOLE |
| 039483102 | ADM | Archer Daniels | $3.1M | 1.04% | 50,000 | Common | SOLE |
| 00484MAB2 | — | Acorda Theraputics | $2.9M | 0.95% | 5,000,000 | Common | SOLE |
| 868459108 | SUPN | Supernus | $2.8M | 0.93% | 82,105 | Common | SOLE |
| N51517105 | 4PKB | Lava Theraputics | $2.6M | 0.85% | 771,874 | Common | SOLE |
| 651639106 | NEM | Newmont | $2.4M | 0.78% | 65,600 | Common | SOLE |
| 50015M109 | KOD | Kodiak Sciences | $2.2M | 0.74% | 423,000 | Common | SOLE |
| 82968B103 | SIRIEUR | XM Sirius | $2.2M | 0.72% | 557,843 | Common | SOLE |
| 925815102 | VICR | Vicor | $1.7M | 0.57% | 45,000 | Common | SOLE |
| 00430HAC6 | — | Accelerate Diagnostic | $1.5M | 0.50% | 3,133,920 | Common | SOLE |
| 044209104 | — | Ashland | $1.5M | 0.48% | 15,000 | Common | SOLE |
| 31189P102 | FATE | Fate Theraputics | $1.0M | 0.35% | 143,000 | Common | SOLE |
| 142038108 | CRBU | Caribu Biosciences | $1.0M | 0.34% | 200,000 | Common | SOLE |
| 56400P706 | MNKD | Mannkind | $883,681 | 0.29% | 195,073 | Common | SOLE |
| 92556V106 | VTRS | Viatris | $695,529 | 0.23% | 58,252 | Common | SOLE |
| 449585108 | 1K0 | IGM Bioscience | $627,250 | 0.21% | 65,000 | Common | SOLE |
| 68622V106 | OGN | Organon | $586,372 | 0.19% | 31,190 | Common | SOLE |
| 65443P102 | MASS | 908 Devices | $515,559 | 0.17% | 68,286 | Common | SOLE |
| 71535D106 | PSNL | Personalis | $447,000 | 0.15% | 300,000 | Common | SOLE |
| 749607107 | RLI | RLI | $296,940 | 0.10% | 2,000 | Common | SOLE |
| 934423104 | WBD | Warner Bros. Discovery | $92,905 | 0.03% | 10,642 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.